Results obtained from observational studies indicate that the use of TNF-α inhibitors in rheumatoid arthritis (RA) patients is associated with a lower DM incidence and better metabolic control compared to non-biological agents [60, 61]. Here, TNF is linked to rheumatoid arthritis.